About U.S. Cancer Statistics
The United States Cancer Statistics are the official government statistics on cancer. These statistics include cancer registry data from CDC and the National Cancer Institute (NCI), as well as mortality data from CDC’s National Center for Health Statistics. The statistics provide information on newly diagnosed cancer cases and cancer deaths for the whole U.S. population.
The combined data from CDC’s National Program of Cancer Registries (NPCR) and NCI’s Surveillance, Epidemiology, and End Results (SEER) Program provide cancer information on 100% of the U.S. population. This national coverage enables the public, including researchers, clinicians, policy makers, and public health professionals, to—
- Monitor populations most affected by cancer.
- Evaluate the success of programs designed to prevent cancer and diagnose cancer at early stages.
- Identify additional needs for cancer prevention and control efforts at national, state, and local levels.
The CDC-funded NPCR is a population-based surveillance system of cancer registries established in 1992. NPCR supports the collection of high-quality data by central cancer registries through funding, technical assistance, and the development of software for collecting and processing data. NPCR works to release the data in accessible, discoverable, and usable formats. Through NPCR, CDC supports central cancer registries in 46 states, the District of Columbia, Puerto Rico, the U.S. Pacific Island Jurisdictions, and the U.S. Virgin Islands.
The NCI-funded SEER Program was established in 1973 and is a population-based surveillance system that collects data from various cancer registries. SEER is an authoritative source of information on cancer incidence and survival in the United States. SEER collects and publishes cancer incidence and survival data from population-based cancer registries in 20 U.S. geographic areas, including 5 states.
Researchers, clinicians, cancer registrars, public health officials, legislators, policy makers, community groups, and members of the public use SEER data to—
- Evaluate cancer prevention and screening programs and the quality of cancer care.
- Document racial and sex disparities.
- Demonstrate the effectiveness of public health interventions.
- Guide the translation of research into health policy and practice.
- Questions and Answers: A list of frequently asked questions and answers.
- Hints for Reading Tables and Graphs: Tips and guidance for reading and understanding the tables and graphs presented in this report.
- Uses for Report Data: Examples of current and possible uses of U.S. Cancer Statistics data.
- Contact Information: Contact information for U.S. Cancer Statistics and for state cancer registries.
- Glossary: An alphabetical list of technical terms and acronyms related to cancer data collection, analysis, and interpretation.
- Technical Notes: A detailed description of data sources, registry eligibility criteria, populations covered, statistical methods, and more.
Partners crucial to the success of cancer registration and cancer surveillance in the United States include the American Cancer Society, the American College of Surgeons, the American Joint Committee on Cancer, the National Cancer Registrars Association, and the North American Association of Central Cancer Registries.
U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2014 Incidence and Mortality Web-based Report. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2017. Available at: www.cdc.gov/uscs.